Physician profile
Michael R Smith
NPI 1558557546
$1,826.55
in general payments reported to CMS, 2019-2025
22 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,445 · 2022: $173 · 2024: $65.04 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $207.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $363.48 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $221.91 | 2021-2022 | |
| Abbvie INC. | $195.53 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $135.48 | 2021 | |
| Grt US Holding, INC. | $108.40 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $98.36 | 2021 | |
| Orthofix Medical, INC. | $89.71 | 2025 | Physio-Stim |
| Arbor Pharmaceuticals, INC. | $89.14 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $67.91 | 2021 | |
| Medtronic, INC. | $65.04 | 2024 | Intellis Adaptivestim |
| Scilex Pharmaceuticals INC. | $55.36 | 2021 | |
| Almatica Pharma LLC | $54.22 | 2021 | |
| Pfizer INC. | $53.91 | 2021 | |
| Abiomed | $53.14 | 2025 | |
| Pacira Therapeutics, INC. | $48.22 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $41.06 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.30 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $15.67 | 2022 | |
| Ibsa Pharma INC. | $14.45 | 2021 | |
| Nalu Medical, INC. | $14.00 | 2022 | |
| Amgen INC. | $13.18 | 2021 | |
| Lilly USA, LLC | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.